Last reviewed · How we verify

Nerve block with Lidocain

Tehran University of Medical Sciences · FDA-approved active Small molecule

Lidocaine blocks sodium channels in nerve fibers, preventing the generation and propagation of action potentials to produce local anesthesia.

Lidocaine blocks sodium channels in nerve fibers, preventing the generation and propagation of action potentials to produce local anesthesia. Used for Local and regional anesthesia via nerve block, Pain management in surgical and procedural settings.

At a glance

Generic nameNerve block with Lidocain
SponsorTehran University of Medical Sciences
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that works by inhibiting sodium influx through voltage-gated sodium channels in nerve cell membranes. This prevents depolarization and action potential generation in sensory and motor nerves. When administered as a nerve block, it reversibly interrupts nerve conduction in a specific anatomical region, providing localized anesthesia without systemic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: